U.S. FDA Approves CARVYKTI™ (ciltacabtagene autoleucel), Janssen’s First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
HORSHAM, Pa., February 28, 2022 – The Janssen Pharmaceutical Companies of…
Dónde ver las películas nominadas al Oscar | Entretenimiento
NUEVA YORK (AP) — ¿Quieres ver las películas nominadas al Oscar…
Queen Elizabeth Commemorates Platinum Jubilee, Marking 70-Year Reign
LONDON — Seventy years ago this weekend, a young English princess…
Could the Novavax Vaccine Help Us Win This COVID War?
It is often said that we are at war with COVID-19.…
Biden’s ‘minor incursion’ comment roils diplomatic efforts to halt Russian invasion of Ukraine
WASHINGTON — The White House on Thursday sought to clarify remarks by…
